The role of mu and kappa opioid receptors within the periaqueductal gray in the expression of conditional hypoalgesia

Brain Research

Volumn 791, Issue 1-2, 1998, Pages 83-89

  Bellgowan, Patrick S F ^a   Helmstetter, Fred J ^a  

^a UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Analgesia; Learning; Nociception; Opioid; Pavlovian conditioning; Periaqueductal gray; Stress; Tail flick

Indexed keywords

DEXTRO PHENYLALANYLCYSTEINYLTYROSYL DEXTRO TRYPTOPHYLORNITHYLTHREONYLPENICILLAMINYLTHREONINAMIDE 2,7 DISULFIDE; GLUTAMIC ACID; KAPPA OPIATE RECEPTOR; KAPPA OPIATE RECEPTOR ANTAGONIST; MU OPIATE RECEPTOR; MU OPIATE RECEPTOR ANTAGONIST; NORBINALTORPHIMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; AUDITORY STIMULATION; CONDITIONED REFLEX; CONTROLLED STUDY; FEAR; HYPOALGESIA; LATENT PERIOD; MALE; NOCICEPTION; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; PRIORITY JOURNAL; RAT; SHOCK; TAIL FLICK TEST; WHITE NOISE;

EID: 0032571778     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00057-2     Document Type: Article

References (38)

1. Bandler R., Depaulis A. Elicitation of intraspecific defence reactions in the rat midbrain periaqueductal grey by microinjection of kainic acid, without neurotoxic effects. Neurosci. Lett. 88:1988;291-296.
2. Bandler R., Keay K.A. Columnar organization in the midbrain periaqueductal gray and the integration of emotional expression. Prog. Brain Res. 107:1996;285-300.
3. Bandler R., Shipley M.T. Columnar organization in the midbrain periaqueductal gray: modules for emotional expression? Trends Neurosci. 17:1994;379-389.
4. Barbaro N.M., Heinricher M.M., Fields H.L. Putative pain modulating neurons in the rostral ventral medulla: reflex related activity predicts effects of morphine. Brain Res. 366:1986;203-210.
5. Basbaum A.I., Fields H.L. Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7:1984;309-338.
6. Bellgowan P.S.F., Helmstetter F.J. Neural Systems for the expression of hypoalgesia during non-associative fear. Behav. Neurosci. 110:1996;727-736.
7. Bellgowan P.S.F., Helmstetter F.J., Bailey D.J. Amygdala and periaqueductal gray subdivisions necessary for the acquisition and performance of discrete and contextual fear conditioning. Soc. Neurosci. Abstr. 22:1996;1116.
8. Cannon J.T., Prieto G.J., Lee A., Liebeskind J.C. Evidence or opioid and non-opioid forms of stimulation-produced analgesia in the rat. Brain Res. 243:1982;315-321.
9. Depaulis A., Keay K.A., Bandler R. Longitudinal neuronal organization of defensive reactions in the midbrain periaqueductal gray region of the rat. Exp. Brain Res. 90:1992;307-318.
10. M.S. Fanselow, The midbrain periaqueductal gray as a coordinator of action in response to fear and anxiety, in: A. Depaulis, R. Bandler (Eds.), The Midbrain Periaqueductal Gray Matter, Plenum, New York, 1991, pp. 151-174.
11. Fanselow M.S., Calcagnetti D.J., Helmstetter F.J. The role of mu and kappa opioid receptors in conditional fear-induced analgesia: the antagonistic actions of nor-binaltorphimine and the cyclic somatostatin octapeptide. CTOP J. Pharmacol. Exp. Ther. 250:1989;825-830.
12. Fields H.L., Heinricher M.M., Mason P. Neurotransmitters in nociceptive modulatory circuits. Annu. Rev. Neurosci. 14:1991;219-246.
13. Helmstetter F.J. The amygdala is essential for the expression of conditional hypoalgesia. Behav. Neurosci. 106:1992;518-528.
14. Helmstetter F.J., Bellgowan P.S. Lesions of the amygdala block conditional hypoalgesia on the tail flick test. Brain Res. 612:1993;253-257.
15. Helmstetter F.J., Bellgowan P.S.F., Poore L.H. Microinfusion of mu, but not delta or kappa opioid agonists into the basolateral amygdala results in inhibition of the tail flick reflex in pentobarbital-anesthetized rats. J. Pharmacol. Exp. Ther. 275:1995;381-388.
16. Helmstetter F.J., Landeira-Fernandez J. Conditional hypoalgesia is attenuated by naltrexone applied to the PAG. Brain Res. 537:1990;88-92.
17. Helmstetter F.J., Tershner S. Lesions of the periaqueductal gray and rostral ventromedial medulla disrupt antinociception but not cardiovascular aversive conditional responses. J. Neurosci. 14:1994;7099-7108.
18. Helmstetter F.J., Tershner S.A., Poore L.H., Bellgowan P.S.F. Antinociception following opioid stimulation of the basolateral amygdala is expressed through the periaqueductal gray and rostral ventromedial medulla. Brain Res. 779:1997;104-118.
19. Jensen T.S., Yaksh T.L. Comparison of the antinociceptive effect of morphine and L-glutamate at coincidental sites in the periaqueductal gray and medial medulla in rats. Brain Res. 476:1989;1-9.
20. Keay K.A., Bandler R. Deep and superficial noxious stimulation increases Fos-like immunoreactivity in different regions of the midbrain periaqueductal grey of the rat. Neurosci. Lett. 154:1993;23-26.
21. Keay K.A., Clement C.I., Owler B., Depaulis A., Bandler R. Convergence of deep somatic and visceral nociceptive information onto a discrete ventrolateral midbrain periaqueductal gray region. Neuroscience. 61:1994;727-732.
22. J.J. Kim, R.A. Rison, M.S. Fanselow, Effects of amygdala, hippocampus and periaqueductal gray lesions on short- and long-term contextual fear, Behav. Neurosci., 107, pp. 1093-1098.
23. Lovick T.A. Ventrolateral medullary lesions block the antinociceptive and cardiovascular responses elicited by stimulating the dorsal periaqueductal grey matter in rats. Pain. 21:1985;241-252.
24. T.A. Lovick, Interactions between descending pathways from the dorsal and ventrolateral periaqueductal gray matter in the rat, in: A. Depaulis, R. Bandler (Eds.), The Midbrain Periaqueductal Gray Matter, Plenum, New York, 1991, pp. 101-120.
25. Ma Q.P., Han J.S. Naloxone blocks the release of opioid peptides in periaqueductal gray and N. accumbens induced by intra-amygdaloid injection of morphine. Peptides. 12:1991;1235-1238.
26. Mansour A., Fox C.A., Akil H., Watson S.J. Opioid-receptor mRNA expression in the rat CNS: anatomical and functional implications. TINS. 18:1995;22-29.
27. Mansour A., Khachaturian H., Lewis M.E., Akil H., Watson S.J. Autoradiographic differentiation of mu, delta, and kappa opioid receptors in the rat forebrain and midbrain. J. Neurosci. 7:1987;2445-2464.
28. Negri L., Noviello V., Angeluccii F. Behavioural effects of deltorphins in rats. Eur. J. Pharmacol. 209:1991;163-168.
29. Ossipov M.H., Kovelowski C., Nichols M.L., Hruby V.J., Porreca F. Characterization of supraspinal antinociceptive actions of opioid delta agonist in the rat. Pain. 62:1995;287-293.
30. Pavlovic Z.W., Cooper M.L., Bodnar R.J. Opioid antagonists in the periaqueductal gray inhibit morphine and beta-endorphin analgesia elicited from the amygdala of rats. Brain Res. 741:1996;13-26.
31. G. Paxinos, C. Watson, The Rat Brain in Stereotaxic Coordinates, 2nd edn., Academic Press, New York, 1986.
32. Poore L.H., Helmstetter F.J. Mu opioids in the RVM contribute to antinociception following DAMGO stimulation of the amygdala. Soc. Neurosci. Abstr. 22:1996;116.
33. Reichling D.B., Basbaum A.I. Contribution of brainstem GABAergic circuitry to descending antinociceptive controls: II. Electron microscopic immunocytochemical evidence of GABAergic control over the projection from the periaqueductal gray to the nucleus raphe magnus in the rat. J. Comp. Neurol. 302:1990;378-393.
34. Reichling D.B., Kwiat G.C., Basbaum A.I. Anatomy, physiology and pharmacology of the periaqueductal gray contribution to antinociceptive controls. Prog. Brain Res. 77:1988;31-46.
35. A receptors in the midbrain periaqueductal gray abolishes nociceptive spinal dorsal horn neuronal activity. Eur. J. Pharmacol. 160:1989;163-166.
36. M.S. Shipley, M. Ennis, T.A. Rizvi, M. Behbehani, Topographical specificity of forebrain inputs to the midbrain periaqueductal gray: evidence for discrete longitudinally organized input columns, in: A. Depaulis, R. Bandler (Eds.), The Midbrain Periaqueductal Gray Matter, Plenum, New York, 1991, pp. 101-120.
37. Tershner S.A., Helmstetter F.J. Forebrain activation of descending antinociceptive systems depends on opioid and non-opioid mechanisms in the ventral periaqueductal gray. Soc. Neurosci. Abstr. 22:1996;116.
38. Watkins L.R., Cobelli D.A., Mayer D.J. Classical conditioning of front paw and hind paw footshock induced analgesia (FSIA): naloxone reversibility and descending pathways. Brain Res. 243:1982;119-132.